Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
Clinical trial NCT02943733 · TERMINATED
Trial details
- NCT number
- NCT02943733
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2020-11-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.